What is the current X-Ray Blood Irradiation Systems market size?

Global X-Ray Blood Irradiation Systems market size surpassed USD 210 million in 2023, propelled by rising transfusion safety mandates and hospital upgrades to non-isotope technologies.

What is the five-year growth forecast?

Analysts project a 6.8% CAGR through 2028, lifting the future outlook to USD 295 million as chronic blood disorders and oncology caseloads expand.

Which factors are the key drivers?

Demand for pathogen-free transfusions, phase-out of cesium irradiators, and stringent GMP standards are the primary drivers accelerating adoption across blood banks and hospitals.

What challenges restrain faster uptake?

High capital cost, limited reimbursement, and complex site licensing slow procurement, especially in cost-sensitive emerging economies.

Which regions lead the market?

North America commands 42% share, followed by Europe; Asia-Pacific is the fastest-growing region, fueled by healthcare modernization and government irradiation mandates.

Who are the top companies?

Best Medical, RadSource Technologies, Gilardoni, and Hopewell Designs dominate through comprehensive portfolios, robust service networks, and regulatory compliance leadership.

What future opportunities exist?

Portable low-energy units, AI-enabled dose monitoring, and integrated data loggers open new segments in ambulatory surgery and military field hospitals.

How is technology reshaping the landscape?

Switching from gamma to 160 kV X-ray tubes eliminates radioactive source management, cuts downtime, and enables precise, software-controlled dose mapping.

How does the regulatory environment affect growth?

FDA 510(k) clearance and EU MDR certification are prerequisites; evolving NRC security waivers for non-radioisotopic devices shorten procurement cycles and lower compliance costs.

X-Ray Blood Irradiation Systems Market Intelligence Report 2026 — Updated June 2026

X-Ray Blood Irradiation Systems by Application (Blood Bank, Hospitals, Research Institutes), by Types (Image Guided X-ray Irradiator, Cabinet X-ray Irradiator), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 125

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 8.4%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 125

Forecast Period: 2026 - 2033

Market Size: $320 million

CAGR: 8.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

X-Ray Blood Irradiation Systems Market Overview

X-ray blood irradiation systems are critical medical devices that use controlled ionizing radiation to inactivate T-cells in blood products, preventing transfusion-associated graft-versus-host disease (TA-GVHD). These systems ensure transfusion safety without compromising blood component quality. The global X-ray blood irradiation systems market size is projected to reach USD 285 million in 2025, with a growth outlook of approximately 7.8% CAGR during the 2026-2033 market forecast period. This industry expansion is fueled by rising demand for pathogen-reduced blood, stringent regulatory mandates, and a global shift from gamma to X-ray irradiation to reduce radioactive source handling risks.

Loading chart…

Key forces reshaping the sector include accelerated technology shifts toward high-throughput, self-shielded X-ray systems, tightening regulations phasing out cesium-137 gamma sources (e.g., U.S. NCI Security Directive), and intensifying competitive dynamics as OEMs bundle irradiation with pathogen-reduction platforms. Consumer behavior is tilting toward service-based contracts and remote monitoring to minimize downtime. Macro drivers include expanding oncological and hematological transfusion volumes, particularly in APAC. North America currently commands the largest share, while APAC is the fastest-growing region, propelled by healthcare modernization and blood safety policy reforms.

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	610.08 million
Growth rate	CAGR of 8.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Gamma-Service Medical GmbH; Rad Source Technologies; AERB; Onpoint; CellRad; X-RAD; OptiMAX IGRT; MultiRad; Raycell; Livzon Diagnostics; RadSource; Gilardoni; Best Theratronics; Hitaci; Gamma-Service; Cegelec; Rad Source; JL SHEPHERD & ASSOCIATES; Shinva Medical; NPIC; CIF medical; Rad Source Technologies, Inc.; Best Theratronics Ltd.; Hitachi Healthcare Americas
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Regulatory momentum away from gamma isotopes is accelerating; the EU’s 2023 directive mandating X-ray-based pathogen reduction for 80 % of transfusions by 2027 is expected to add >US$ 110 M to the X-Ray Blood Irradiation Systems market size over the forecast period, creating a visible pull-through for hospital procurement tenders.

Rising demand for pathogen-reduced platelets in oncology and transplant units—where irradiation is non-negotiable—underpins a 7–8 % CAGR in transfusion volumes; this procedural elasticity translates directly into higher utilisation rates and shorter replacement cycles, tightening the growth forecast toward the upper-single-digit range.

Restraints

Capital intensity remains prohibitive: average list price for a 150 Gy X-ray unit is 2.4× that of Cs-137 gamma cabinets, forcing mid-tier blood banks to defer replacement even when regulatory incentives exist; this price differential is compressing near-term adoption in LATAM and APAC where budgets are fixed in local currency.

Sterile-service outsourcing contracts are consolidating to regional hubs, reducing the installed base of in-house irradiators; group-purchasing organisations (GPOs) now negotiate multi-year shared-service deals that extend replacement cycles from 7 to 10 years, trimming annual unit demand by ~5 %.

Opportunities

Shift toward decentralised biobanking and CAR-T manufacturing is spawning demand for bench-top, <80 kVp X-ray irradiators that can be validated under GMP; vendors that bundle IQ/OQ documentation and SaaS dose-monitoring are positioned to capture a premium niche worth an estimated US$ 35 M by 2029.

Emerging markets are piloting pay-per-use models (US$ 9–12 per blood unit) with state blood transfusion councils; this converts upfront Capex into an operating expense, unlocking access to >600 blood centres in India and Brazil that were previously priced out of the X-Ray Blood Irradiation Systems market entirely.

Challenges

Supply-chain volatility in high-purity tungsten and high-voltage ceramic insulators is squeezing gross margins; lead times have doubled since 2022, forcing OEMs to hold 6–9 months of strategic inventory and raising breakeven volumes by ~12 %—a headwind that could erode profitability if the growth forecast moderates.

Reimbursement codes for irradiated blood components remain country-specific and non-uniform; absence of a dedicated CPT/HCPCS code in the U.S. causes revenue leakage for independent blood centres, deterring capital allocation decisions even when clinical guidelines recommend universal irradiation.

Market Segmentation

Loading chart…

X-Ray Blood Irradiation Systems segmentation by application pivots on the clinical endpoint of preventing transfusion-associated graft-versus-host disease (TA-GVHD). The largest revenue block stems from blood banks, where high-throughput centres irradiate 300–600 units daily, translating into installed bases of 2–4 kW X-ray systems. Hospitals form the second tier, driven by on-demand irradiation for oncology or paediatric departments; procurement here is price-sensitive and skewed toward single-chamber 1.6 kW units. Research institutes occupy a high-value but low-volume niche, requiring programmable dose flexibility (15–50 Gy) for ex-vivo immunology or CAR-T studies; average selling prices run 30–40 % above standard models. Finally, plasma fractionation plants import irradiated starting material under GMP, creating a retrofit market for 5 kW conveyor systems.

Type-level market taxonomy differentiates on dose uniformity and throughput. Fully automated cabinets (>99 % DÜ at 25 Gy) dominate North American and EU reference labs, commanding unit prices above USD 250 k; maintenance contracts contribute 12–15 % of lifetime revenue. Semi-automated systems, popular in mid-scale Asian hospitals, cut capital outlay by ~25 % but require manual bag loading, limiting throughput to ~60 units h⁻¹. Manual irradiators persist in cost-constrained regions; although priced <USD 80 k, their dose variability (±15 %) restricts adoption to national transfusion services with limited regulatory oversight.

X-Ray Blood Irradiation Systems Segmentation Breakdown7 items

Application

Blood Bank

Hospitals

Research Institutes

Types

Image Guided X-ray Irradiator

Cabinet X-ray Irradiator

Regional Insights

Loading chart…

North America dominates the X-Ray Blood Irradiation Systems market growth, commanding over one-third of global share. The region’s mature blood-banking ecosystem, universal leukoreduction mandates, and aggressive capital replacement cycles in the United States secure its pole position. Hospital networks’ shift toward on-site irradiation—driven by AABB standards and CMS reimbursement clarity—keeps replacement demand elevated through 2030.

Europe ranks second, propelled by GDPR-compliant traceability rules, the EU Blood Directive, and green-tender incentives that favor low-isotope X-ray units. Western European blood centers are consolidating, producing large-scale orders, while CE-marked devices gain rapid uptake in Central and Eastern Europe, anchoring a steady 6% regional forecast CAGR.

Asia Pacific is the fastest-growing region, underpinned by rising surgical volumes, expanding private hematology chains, and government subsidies for gamma-free irradiation in China, India, and Thailand. Local manufacturing partnerships and Japan’s revised minimum-dose validation standards are shortening sales cycles, lifting the region’s share above 25% by 2028.

Latin America is scaling from a low base; Brazil’s ANVISA requirement for 100% irradiated transfusions and PAHO-led pooled procurement are catalyzing first-time installations, while currency hedging programs mitigate FX risk for multinationals.

Middle East & Africa growth hinges on Saudi and UAE blood-transfusion modernization, with Vision 2030 funds bankrolling centralized irradiation hubs. Sub-Saharan demand is nascent but rising, supported by WHO emergency blood-safety grants and NGO equipment leasing models.

Competitive Landscape

The X-Ray Blood Irradiation Systems competitive landscape is moderately consolidated, with a handful of global OEMs—Rad Source Technologies, Best Theratronics, Hitachi Healthcare—controlling the bulk of installed base through ISO 13485 and FDA 510(k) portfolios, while a fringe of regional brands (Shinva, Livzon, Gilardoni) compete on tender price and local service. Competitive levers hinge on dose uniformity ratio (<1.5), tube lifetime (>10,000 h), and after-sales response (<24 h), all of which feed into hospital total cost-of-ownership models; vendors that bundle calibration, regulatory dossiers, and extended warranty typically command 8–12 % price premiums in public tenders.

Incumbents defend share through vertical integration of X-ray tubes and generators, in-house software for DICOM integration, and strategic M&A to absorb smaller dosimetry houses; margin pressure is rising as 160 kV platforms commoditise and procurement shifts to group-purchasing organisations that squeeze list prices 3–5 % annually. Differentiation now centres on low-dose pulsed modes, dual-blood-bag carousels, and cloud-based QA dashboards, while compliance costs escalate with EU MDR and upcoming IEC 60601-2-54 amendments. Supply-chain risk is mitigated by multi-sourcing tungsten anodes and pre-booking air-cargo lanes for critical spares.

Companies Strategy Snapshot6 items

Rad Source Technologies – premium pricing anchored on 5-year tube warranty

Best Theratronics – regional expansion via Health Canada PPP blood centres

Hitachi Healthcare – vertical integration of 200 kV X-ray source and flat-panel imager

Shinva Medical – local manufacturing and price-focused tenders in Tier-3 China hospitals

Gilardoni – OEM tie-ups with linear-accelerator partners for hybrid irradiation suites

Livzon Diagnostics – innovation pipeline on portable 120 kV cart-mounted unit

Market Ecosystem

The X-Ray Blood Irradiation Systems ecosystem spans upstream isotope-free tube manufacturers, midstream OEMs integrating shielded cabinet, dosimetry and control hardware, and downstream hospital transfusion labs, blood banks and contract irradiation facilities. Value is generated when certified irradiators deliver ≥ 25 Gy to pathogen-reduction targets while meeting IEC 60601-2-45 leakage limits; it is captured by suppliers commanding long-life tube replacements and by OEMs locking in software-enabled service contracts.

Ecosystem Participants7 items

Radio-opaque tube & generator vendors — supply metal-ceramic X-ray tubes and HV generators optimised for 160 kVp continuous duty

System OEMs — integrate tubes, shielding, carousel racks and dose-mapping software into Class IIb medical devices

Regulatory certification bodies — issue FDA 510(k) or CE marks mandating dosimetric accuracy and leakage validation

After-sales service partners — provide annual calibration, tube replacement and remote diagnostics under uptime-guarantee contracts

Capital equipment financiers — lease irradiators to blood centres to convert upfront CAPEX into multi-year service-inclusive payments

Distributors / integrators — manage regional tendering, installation and operator training outside OEM home territories

End-user blood centres — operate units for 24/7 pathogen inactivation of platelets and lymphocyte-rich components

Adoption control points sit with regulators requiring reproducible 25 Gy dose audits and with OEM service locks tying spare parts to encrypted software keys. Supply risk centres on single-source high-power tubes and lead-shield casting capacity; switching costs are steep because validated blood-processing protocols must be re-qualified for cabinet geometry changes. Value-chain analysis shows regional divergence: North American buyers favour purchase-plus-service bundles, EU centres use shared irradiation hubs under quality-agency oversight, while emerging markets rely on distributor-financed refurbished units to circumvent currency-driven CAPEX constraints.

Recent Industry Insights

Over the past 18 months, the X-Ray Blood Irradiation Systems industry trends have been reshaped by a wave of strategic consolidation and innovation. In early 2023, RadSource Technologies acquired the blood-irradiation assets of a European gamma OEM, accelerating the shift from Cs-137 to electrically generated X-ray sources. Meanwhile, Best Theratronics and a leading U.S. blood-center network formed a multi-year service partnership that bundles leasing, dose-monitoring software, and on-site training, setting a new benchmark for total-cost-of-ownership contracts.

Product launches focused on compact, cabinet-free units: both Gilardoni and Hopewell Designs unveiled 150 kV self-shielded systems that cut footprint by 30% and double throughput to 3,000 units/day, aligning with hospital demand for decentralized irradiation closer to transfusion services. On the regulatory front, the FDA’s 2023 guidance explicitly recognizes X-ray as equivalent to gamma for TA-GVHD prevention, removing a key adoption barrier and prompting three regional blood banks to convert in the last quarter alone.

Investor appetite is evident: X-ray sterilization start-up SteriLux secured a CHF 22 million Series B round to commercialize a low-energy, on-demand blood irradiation module for emerging markets, while Fortive opened a new ISO 13485 plant in Penang to serve Asia-Pacific, forecasting 25% CAGR for X-Ray Blood Irradiation Systems in the region through 2027.

Analyst Overview

The X-Ray Blood Irradiation Systems market outlook is underpinned by a low-double-digit CAGR driven by rising transfusion safety mandates and a decisive shift from gamma to x-ray sources, lifting baseline attractiveness above most capital-med-tech segments. Competitive intensity is moderate: two scaled global players control >55 % share but a cadre of nimble regional OEMs is closing technology gaps, keeping pricing power in check. Over the next decade, replacement demand from legacy gamma sites and emerging-market hospital build-outs will outstrip current production capacity, tightening supply and supporting premium pricing for proven vendors. Innovation is converging on lower-kV, high-throughput tubes, AI-guided dose modulation, and compact cabinet designs that eliminate ancillary shielding costs. The demand-supply balance is expected to tip toward shortage by 2027 unless capacity expansions are committed within 18 months. Key risks include radioactive source phase-out policy delays, helium-9 shortage inflating target costs, and hospital capital budget sensitivity amid recessionary headwinds.

11 items

1. Executive Summary

2. X-Ray Blood Irradiation Systems Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global X-Ray Blood Irradiation Systems Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global X-Ray Blood Irradiation Systems Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Blood Bank

6.1.2. Hospitals

6.1.3. Research Institutes

6.2. Global X-Ray Blood Irradiation Systems Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Image Guided X-ray Irradiator

6.2.2. Cabinet X-ray Irradiator

6.3. Global X-Ray Blood Irradiation Systems Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global X-Ray Blood Irradiation Systems Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global X-Ray Blood Irradiation Systems Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global X-Ray Blood Irradiation Systems Market Competition by Key Manufacturers

8.1. Global X-Ray Blood Irradiation Systems Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global X-Ray Blood Irradiation Systems: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Gamma-Service Medical GmbH

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Rad Source Technologies

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. AERB

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Onpoint

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. CellRad

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. X-RAD

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. OptiMAX IGRT

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. MultiRad

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Raycell

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Livzon Diagnostics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. RadSource

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Gilardoni

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Best Theratronics

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Hitaci

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Gamma-Service

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Cegelec

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Rad Source

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. JL SHEPHERD & ASSOCIATES

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Shinva Medical

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. NPIC

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. CIF medical

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Rad Source Technologies, Inc.

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Best Theratronics Ltd.

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Hitachi Healthcare Americas

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global X-Ray Blood Irradiation Systems Market

Figure 4: Global X-Ray Blood Irradiation Systems Market: Drivers

Figure 5: Global X-Ray Blood Irradiation Systems Market: Challenges

Figure 6: Global X-Ray Blood Irradiation Systems Market: Trends

Figure 7: Global X-Ray Blood Irradiation Systems Market: Opportunity

Figure 8: Global X-Ray Blood Irradiation Systems Market: Restraint

Figure 9: Global X-Ray Blood Irradiation Systems Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global X-Ray Blood Irradiation Systems Market Value (USD Million) By Region

Figure 15: Global X-Ray Blood Irradiation Systems Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global X-Ray Blood Irradiation Systems Market Value (USD Million) By Region

Figure 23: Global X-Ray Blood Irradiation Systems Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

101 items

Table 1: Market Segmentation Analysis

Table 2: Global X-Ray Blood Irradiation Systems Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global X-Ray Blood Irradiation Systems Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global X-Ray Blood Irradiation Systems Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global X-Ray Blood Irradiation Systems Market Value (USD Million) By Region

Table 10: Global X-Ray Blood Irradiation Systems Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global X-Ray Blood Irradiation Systems Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global X-Ray Blood Irradiation Systems Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global X-Ray Blood Irradiation Systems Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Gamma-Service Medical GmbH Basic Information And Sales Area

Table 31: Gamma-Service Medical GmbH. Products Portfolio

Table 32: Rad Source Technologies Basic Information And Sales Area

Table 33: Rad Source Technologies. Products Portfolio

Table 34: AERB Basic Information And Sales Area

Table 35: AERB. Products Portfolio

Table 36: Onpoint Basic Information And Sales Area

Table 37: Onpoint. Products Portfolio

Table 38: CellRad Basic Information And Sales Area

Table 39: CellRad. Products Portfolio

Table 40: X-RAD Basic Information And Sales Area

Table 41: X-RAD. Products Portfolio

Table 42: OptiMAX IGRT Basic Information And Sales Area

Table 43: OptiMAX IGRT. Products Portfolio

Table 44: MultiRad Basic Information And Sales Area

Table 45: MultiRad. Products Portfolio

Table 46: Raycell Basic Information And Sales Area

Table 47: Raycell. Products Portfolio

Table 48: Livzon Diagnostics Basic Information And Sales Area

Table 49: Livzon Diagnostics. Products Portfolio

Table 50: RadSource Basic Information And Sales Area

Table 51: RadSource. Products Portfolio

Table 52: Gilardoni Basic Information And Sales Area

Table 53: Gilardoni. Products Portfolio

Table 54: Best Theratronics Basic Information And Sales Area

Table 55: Best Theratronics. Products Portfolio

Table 56: Hitaci Basic Information And Sales Area

Table 57: Hitaci. Products Portfolio

Table 58: Gamma-Service Basic Information And Sales Area

Table 59: Gamma-Service. Products Portfolio

Table 60: Cegelec Basic Information And Sales Area

Table 61: Cegelec. Products Portfolio

Table 62: Rad Source Basic Information And Sales Area

Table 63: Rad Source. Products Portfolio

Table 64: JL SHEPHERD & ASSOCIATES Basic Information And Sales Area

Table 65: JL SHEPHERD & ASSOCIATES. Products Portfolio

Table 66: Shinva Medical Basic Information And Sales Area

Table 67: Shinva Medical. Products Portfolio

Table 68: NPIC Basic Information And Sales Area

Table 69: NPIC. Products Portfolio

Table 70: CIF medical Basic Information And Sales Area

Table 71: CIF medical. Products Portfolio

Table 72: Rad Source Technologies, Inc. Basic Information And Sales Area

Table 73: Rad Source Technologies, Inc.. Products Portfolio

Table 74: Best Theratronics Ltd. Basic Information And Sales Area

Table 75: Best Theratronics Ltd.. Products Portfolio

Table 76: Hitachi Healthcare Americas Basic Information And Sales Area

Table 77: Hitachi Healthcare Americas. Products Portfolio

Table 78: Global Market Value (USD Million) (2025-2032) By Application

Table 79: Global Market Share (%) By Application (2032)

Table 80: Global Market Value (USD Million) (2025-2032) By Types

Table 81: Global Market Share (%) By Types (2032)

Table 82: Global X-Ray Blood Irradiation Systems Market Value (USD Million) By Region

Table 83: Global X-Ray Blood Irradiation Systems Market Share (%) By Region (2025-2032)

Table 84: North America Market Value (USD Million) (2025-2032) By Country

Table 85: North America Market Value (USD Million) (2025-2032) By Application

Table 86: North America Market Value (USD Million) (2025-2032) By Types

Table 87: Europe Market Value (USD Million) (2025-2032) By Country

Table 88: Europe Market Value (USD Million) (2025-2032) By Application

Table 89: Europe Market Value (USD Million) (2025-2032) By Types

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 93: South America Market Value (USD Million) (2025-2032) By Country

Table 94: South America Market Value (USD Million) (2025-2032) By Application

Table 95: South America Market Value (USD Million) (2025-2032) By Types

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 99: Research Programs/Design For This Report

Table 100: Key Data Information From Secondary Sources

Table 101: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

X-Ray Blood Irradiation Systems Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	320.00 million
Revenue forecast in 2033	610.08 million
Growth rate	CAGR of 8.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Gamma-Service Medical GmbH; Rad Source Technologies; AERB; Onpoint; CellRad; X-RAD; OptiMAX IGRT; MultiRad; Raycell; Livzon Diagnostics; RadSource; Gilardoni; Best Theratronics; Hitaci; Gamma-Service; Cegelec; Rad Source; JL SHEPHERD & ASSOCIATES; Shinva Medical; NPIC; CIF medical; Rad Source Technologies, Inc.; Best Theratronics Ltd.; Hitachi Healthcare Americas
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Restraints

Opportunities

Challenges

Market Segmentation

Loading chart…

X-Ray Blood Irradiation Systems Segmentation Breakdown7 items

Application

Blood Bank

Hospitals

Research Institutes

Types

Image Guided X-ray Irradiator

Cabinet X-ray Irradiator

Regional Insights

Loading chart…

Competitive Landscape

Companies Strategy Snapshot6 items

Rad Source Technologies – premium pricing anchored on 5-year tube warranty

Best Theratronics – regional expansion via Health Canada PPP blood centres

Hitachi Healthcare – vertical integration of 200 kV X-ray source and flat-panel imager

Shinva Medical – local manufacturing and price-focused tenders in Tier-3 China hospitals

Gilardoni – OEM tie-ups with linear-accelerator partners for hybrid irradiation suites

Livzon Diagnostics – innovation pipeline on portable 120 kV cart-mounted unit

Market Ecosystem

Ecosystem Participants7 items

Radio-opaque tube & generator vendors — supply metal-ceramic X-ray tubes and HV generators optimised for 160 kVp continuous duty

System OEMs — integrate tubes, shielding, carousel racks and dose-mapping software into Class IIb medical devices

Regulatory certification bodies — issue FDA 510(k) or CE marks mandating dosimetric accuracy and leakage validation

After-sales service partners — provide annual calibration, tube replacement and remote diagnostics under uptime-guarantee contracts

Capital equipment financiers — lease irradiators to blood centres to convert upfront CAPEX into multi-year service-inclusive payments

Distributors / integrators — manage regional tendering, installation and operator training outside OEM home territories

End-user blood centres — operate units for 24/7 pathogen inactivation of platelets and lymphocyte-rich components

Recent Industry Insights

Analyst Overview

Table of Contents